Transforming Growth Factor-β1 Regulates Cdk5 Activity in Primary Sensory Neurons
Open Access
- 1 May 2012
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (20) , 16917-16929
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK AntagonismScience, 2011
- Inflammatory Pain Signals an Increase in Functional Expression of Organic Anion Transporting Polypeptide 1a4 at the Blood-Brain BarrierThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Resveratrol Inhibits Cdk5 Activity through Regulation of p35 ExpressionMolecular Pain, 2011
- Ablation of Rat TRPV1-Expressing Adelta/C-Fibers with Resiniferatoxin: Analysis of Withdrawal Behaviors, Recovery of Function and Molecular CorrelatesMolecular Pain, 2010
- Thermal Nociceptive Properties of Trigeminal Afferent Neurons in RatsMolecular Pain, 2010
- Molecular roles of Cdk5 in pain signalingDrug Discovery Today: Therapeutic Strategies, 2009
- Tumor Necrosis Factor-α Regulates Cyclin-dependent Kinase 5 Activity during Pain Signaling through Transcriptional Activation of p35Journal of Biological Chemistry, 2009
- Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1Proceedings of the National Academy of Sciences, 2007
- Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathologyJournal of Clinical Investigation, 2006
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992